Literature DB >> 15243138

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes.

Jonathan Satin1, Izhak Kehat, Oren Caspi, Irit Huber, Gil Arbel, Ilanit Itzhaki, Janos Magyar, Elizabeth A Schroder, Ido Perlman, Lior Gepstein.   

Abstract

Human embryonic stem cell-derived cardiomyocytes (hES-CMs) are thought to recapitulate the embryonic development of heart cells. Given the exciting potential of hES-CMs as replacement tissue in diseased hearts, we investigated the pharmacological sensitivity and ionic current of mid-stage hES-CMs (20-35 days post plating). A high-resolution microelectrode array was used to assess conduction in multicellular preparations of hES-CMs in spontaneously contracting embryoid bodies (EBs). TTX (10 microm) dramatically slowed conduction velocity from 5.1 to 3.2 cm s(-1) while 100 microm TTX caused complete cessation of spontaneous electrical activity in all EBs studied. In contrast, the Ca2+channel blockers nifedipine or diltiazem (1 microm) had a negligible effect on conduction. These results suggested a prominent Na+ channel current, and therefore we patch-clamped isolated cells to record Na+ current and action potentials (APs). We found for isolated hES-CMs a prominent Na+ current (244 +/- 42 pA pF(-1) at 0 mV; n=19), and a hyperpolarization-activated current (HCN), but no inward rectifier K+ current. In cell clusters, 3 microm TTX induced longer AP interpulse intervals and 10 microm TTX caused cessation of spontaneous APs. In contrast nifedipine (Ca2+ channel block) and 2 mm Cs+ (HCN complete block) induced shorter AP interpulse intervals. In single cells, APs stimulated by current pulses had a maximum upstroke velocity (dV/dtmax) of 118 +/- 14 V s(-1) in control conditions; in contrast, partial block of Na+ current significantly reduced stimulated dV/dtmax (38 +/- 15 V s(-1)). RT-PCR revealed NaV1.5, CaV1.2, and HCN-2 expression but we could not detect Kir2.1. We conclude that hES-CMs at mid-range development express prominent Na+ current. The absence of background K+ current creates conditions for spontaneous activity that is sensitive to TTX in the same range of partial block of NaV1.5; thus, the NaV1.5 Na+ channel is important for initiating spontaneous excitability in hES-derived heart cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243138      PMCID: PMC1665128          DOI: 10.1113/jphysiol.2004.068213

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  45 in total

1.  Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture.

Authors:  M Amit; M K Carpenter; M S Inokuma; C P Chiu; C P Harris; M A Waknitz; J Itskovitz-Eldor; J A Thomson
Journal:  Dev Biol       Date:  2000-11-15       Impact factor: 3.582

2.  Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability.

Authors:  Yair Feld; Meira Melamed-Frank; Izhak Kehat; Dror Tal; Shimon Marom; Lior Gepstein
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

Review 3.  Cyclic variation of intracellular calcium: a critical factor for cardiac pacemaker cell dominance.

Authors:  Edward G Lakatta; Victor A Maltsev; Konstantin Y Bogdanov; Michael D Stern; Tatiana M Vinogradova
Journal:  Circ Res       Date:  2003-02-21       Impact factor: 17.367

4.  High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction.

Authors:  Izhak Kehat; Amira Gepstein; Alon Spira; Joseph Itskovitz-Eldor; Lior Gepstein
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

5.  Properties of potassium currents in Purkinje cells of failing human hearts.

Authors:  Wei Han; Liming Zhang; Gernot Schram; Stanley Nattel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08-15       Impact factor: 4.733

Review 6.  Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

7.  Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling.

Authors:  R M Shaw; Y Rudy
Journal:  Circ Res       Date:  1997-11       Impact factor: 17.367

8.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

Review 9.  Derivation and potential applications of human embryonic stem cells.

Authors:  Lior Gepstein
Journal:  Circ Res       Date:  2002-11-15       Impact factor: 17.367

10.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

Authors:  I Kehat; D Kenyagin-Karsenti; M Snir; H Segev; M Amit; A Gepstein; E Livne; O Binah; J Itskovitz-Eldor; L Gepstein
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

View more
  89 in total

1.  Rhythmic beating of stem cell-derived cardiac cells requires dynamic coupling of electrophysiology and Ca cycling.

Authors:  Ihor Zahanich; Syevda G Sirenko; Larissa A Maltseva; Yelena S Tarasova; Harold A Spurgeon; Kenneth R Boheler; Michael D Stern; Edward G Lakatta; Victor A Maltsev
Journal:  J Mol Cell Cardiol       Date:  2010-10-15       Impact factor: 5.000

Review 2.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

Review 3.  Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.

Authors:  Alexander R Lyon; Sian E Harding; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2008-07-16       Impact factor: 4.132

Review 4.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 5.  Mechanisms underlying the cardiac pacemaker: the role of SK4 calcium-activated potassium channels.

Authors:  David Weisbrod; Shiraz Haron Khun; Hanna Bueno; Asher Peretz; Bernard Attali
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

6.  Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures.

Authors:  Udi Nussinovitch; Lior Gepstein
Journal:  Neurophotonics       Date:  2015-06-23       Impact factor: 3.593

Review 7.  Human stem cells and drug screening: opportunities and challenges.

Authors:  Allison D Ebert; Clive N Svendsen
Journal:  Nat Rev Drug Discov       Date:  2010-03-26       Impact factor: 84.694

8.  Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.

Authors:  Changsung Kim; Maryam Majdi; Peng Xia; Karen A Wei; Maria Talantova; Sean Spiering; Brandon Nelson; Mark Mercola; Huei-Sheng Vincent Chen
Journal:  Stem Cells Dev       Date:  2010-06       Impact factor: 3.272

Review 9.  Electrophysiological challenges of cell-based myocardial repair.

Authors:  Huei-Sheng Vincent Chen; Changsung Kim; Mark Mercola
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

10.  SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells.

Authors:  David Weisbrod; Asher Peretz; Anna Ziskind; Nataly Menaker; Shimrit Oz; Lili Barad; Sivan Eliyahu; Joseph Itskovitz-Eldor; Nathan Dascal; Daniel Khananshvili; Ofer Binah; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.